Production and Characterization of Monoclonal Antibodies against Human Malignant Melanoma

References

• Koprowski H, Steplewski Z, Herlyn D, et al. Studies of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci USA 1978; 75: 3405–3409
   PubMed Web of Science ®Google Scholar
• Herlyn M, Clark WH, Mastrangelo MJ, et al. Specific immu-noreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells. Cancer Res 1980; 40: 3602–3609
   PubMed Web of Science ®Google Scholar
• Dippold WG, Lloyd KO, Li L TC, et al. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci USA 1980; 77: 6114–6118
   PubMed Web of Science ®Google Scholar
• Carrel S, Accolla RS, Carmagnola AL, et al. Common melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res 1980; 40: 2523–2528
   PubMed Web of Science ®Google Scholar
• Woodbury RG, Brown JP, Yeh M-Y, et al. Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc Natl Acad Sci USA 1980; 77: 2183–2187
   PubMed Web of Science ®Google Scholar
• Wilson BS, Imai K, Natali PG, et al. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer 1981; 28: 293–300
   PubMed Web of Science ®Google Scholar
• Yeh H-Y, Hellstrom I, Brown JP, et al. Cell surface antigens of human melanoma identified by monoclonal antibody. Proc Natl Acad Sci USA 1979; 76: 2927–2931
   PubMed Web of Science ®Google Scholar
• Woodbury RG, Brown JP, Loop SM, et al. Analysis of normal and neoplastic human tissues for the tumor-associated protein p97. Int J Cancer 1981; 27: 145–149
   PubMed Web of Science ®Google Scholar
• Andrews PW, Bronson DL, Benham I, et al. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int J Cancer 1980; 26: 269–280
   PubMed Web of Science ®Google Scholar
• Steplewski Z, Chang TH, Herlyn M, et al. Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells. Cancer Res 1981; 41: 2723–2727
   PubMed Web of Science ®Google Scholar
• Steplewski Z, Herlyn M, Herlyn D, et al. Reactivity of monoclonal antimelanoma antibodies with melanoma cells freshly isolated from primary and metastatic melanoma. Eur J Immunol 1979; 9: 94–96
   PubMed Web of Science ®Google Scholar
• Ensinger M, Marko O. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 1982; 79: 2018–2022
   PubMed Web of Science ®Google Scholar
• Galanos C, Lüderitz O. Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. Eur J Biochem 1975; 54: 603–610
   PubMedGoogle Scholar
• Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (London) 1975; 257: 495–497
   PubMedGoogle Scholar
• Kearney JF, Radbruch A, Liesegang B, et al. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol 1979; 123: 1548–1550
   PubMed Web of Science ®Google Scholar
• Herlyn M, Steplewski Z, Herlyn D, et al. Colorectal carcinoma-specific antigen: Detection by means of monoclonal antibodies. Proc Natl Acad Sci USA 1979; 76: 1438–1442
   PubMed Web of Science ®Google Scholar
• Herlyn D, Herlyn M, Steplewski Z, et al. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur J Immunol 1979; 9: 657–659
   Google Scholar
• Herlyn DM, Koprowski H. Monoclonal anticolon carcinoma antibodies in complement-dependent cytotoxicity. Int J Cancer 1981; 27: 769–774
   PubMed Web of Science ®Google Scholar
• Mitchell KF, Fuhrer JP, Steplewski Z, et al. Biochemical characterization of human melanoma cell surfaces: dissection with monoclonal antibodies. Proc Natl Acad Sci USA 1980; 77: 7287–7291
   PubMed Web of Science ®Google Scholar
• Mitchell KF, Fuhrer JP, Steplewski Z, et al. Structural characterization of the “melanoma-specific” antigen detected by monoclonal antibody 691I5Nu-4-B. Mol Immunol 1981; 18: 207–218
   PubMed Web of Science ®Google Scholar
• Ross AH, Mitchell KF, Steplewski Z, et al. Identification and isolation of melanoma-associated antigens with monoclonal antibodies. Hybridoma 1982; 1: 413–421
   PubMed Web of Science ®Google Scholar
• Brown JP, Nishiyama K, Hellstrom I, et al. Structural characterization of human melanoma-associated antigen p97 with monoclonal antibodies. J Immunol 1981; 127: 539–546
   PubMed Web of Science ®Google Scholar
• Mitchell KF, Ward FE, Koprowski H. DR antigens on melanoma cells: Analysis with monoclonal antibodies. Human Immunol 1982; 4: 15–26
   PubMed Web of Science ®Google Scholar
• Brown JP, Woodbury RG, Hast CE, et al. Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sci USA 1981; 78: 539–543
   PubMed Web of Science ®Google Scholar
• Brown JP, Hewick RM, Hellstrom I, et al. Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature (London) 1982; 296: 171–173
   PubMed Web of Science ®Google Scholar
• Imai K, Ng AK, Ferrone S. Characterization of monoclonal antibodies to melanoma-associated antigens. J Natl Cancer Inst 1981; 66: 489–496
   PubMed Web of Science ®Google Scholar
• Reisfeld RA, Galloway DR, Morgan AC, et al. Human melanoma-associated antigen. Cancer Bull 1981; 33: 211–218
   Google Scholar
• The Second Workshop on monoclonal antibodies to melanoma. Hybridoma 1982; 1: 379–482
   PubMed Web of Science ®Google Scholar
• Herlyn D, Koprowski H. IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc Natl Acad Sci USA 1982; 79: 4761–4765
   PubMed Web of Science ®Google Scholar